Novel Skin Barrier to Prevent and Treat Poison Ivy
Novel Skin Barrier to Prevent and Treat Poison Ivy
批准号:
6833377
负责人:
Charles J Gauntt
金额:
$13.37万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-10 至 2007-08-31
中文摘要
描述(由申请人提供):
毒藤/橡树皮炎(也称为Toxicodendron皮炎)是美国最常见的过敏性接触性皮炎,每年影响数百万美国人。在一般成年人群中,毒葛和橡树敏感性的患病率在50%至70%之间,皮肤炎症的敏感性和严重程度可以从轻微刺激到需要医疗护理。局部皮质类固醇是治疗毒葛/橡树刺激的主要形式,然而,局部或全身使用皮质类固醇可增强继发感染的趋势。
该项目的目标是评估一种专利聚合物涂层技术作为毒藤和毒橡树皮炎的皮肤屏障和治疗。这种创新的涂层有望提供一种安全、抗菌、抗炎的皮肤屏障产品,可以预防和治疗毒藤/橡树皮炎。
为了证明使用涂层作为屏障和处理的可行性和有效性,将追求以下具体目标:
1.优化用于临床试验的涂层配方和化合物配方
2.评价涂层作为皮肤屏障和治疗人类漆树皮炎的作用
英文摘要
DESCRIPTION (provided by applicant):
Poison ivy/oak dermatitis (also known as Toxicodendron dermatitis) is the most common allergic contact dermatitis in the United States, affecting millions of Americans every year. The prevalence of poison ivy and oak sensitivity in the general adult population ranges from 50 to 70%, and the sensitivity and severity of skin inflammation can range from minor irritation to that which requires medical attention. Topical corticosteroids are the main form of treatment for poison ivy/oak irritations, however the tendency to develop secondary infection can be enhanced by the use of topical or systemic corticosteroids.
The goal of this project is to evaluate a patented polymer-based coating technology as both a skin barrier to and treatment for poison ivy and poison oak dermatitis. The innovative coating is expected to provide a safe, antimicrobial, anti-inflammatory skin barrier product that may prevent and treat poison ivy/oak dermatitis.
In order to demonstrate feasibility and effectiveness of using the coatings as a barrier and treatment, the following Specific Aims will be pursued:
1. Optimize Coating Formulations and Compound Formulations for Clinical Testing
2. Evaluate Coatings as a Skin Barrier and Treatment for Toxicodendron Dermatitis in Humans
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Unique Anti-microbial Rinse to Reduce Oral Inflammation
-
批准号:8123164
-
项目类别:
-
资助金额:$29.99万
-
财政年份:2010
-
负责人:Charles J Gauntt
-
依托单位:
Unique Anti-microbial Rinse to Reduce Oral Inflammation
-
批准号:7928457
-
项目类别:
-
资助金额:$41.04万
-
财政年份:2010
-
负责人:Charles J Gauntt
-
依托单位:
Unique Anti-microbial Rinse to Reduce Oral Inflammation
-
批准号:7671912
-
项目类别:
-
资助金额:$34.48万
-
财政年份:2009
-
负责人:Charles J Gauntt
-
依托单位:
Novel Therapy to Treat Otitis Media
-
批准号:7482156
-
项目类别:
-
资助金额:$10.7万
-
财政年份:2008
-
负责人:Charles J Gauntt
-
依托单位:
Non-Toxic Gel to Treat Vulvovaginal Candidiasis
-
批准号:7051865
-
项目类别:
-
资助金额:$11.03万
-
财政年份:2006
-
负责人:Charles J Gauntt
-
依托单位:
Novel Topical Treatment for Postherpetic Neuralgia
-
批准号:6991051
-
项目类别:
-
资助金额:$19.69万
-
财政年份:2005
-
负责人:Charles J Gauntt
-
依托单位:
Novel Rinse to Treat Oral Candidiasis in Cancer Patients
-
批准号:6989894
-
项目类别:
-
资助金额:$15.95万
-
财政年份:2005
-
负责人:Charles J Gauntt
-
依托单位:
CHRONIC MYOCARDITIS IN A COXSACKIE VIRUS MURINE MODEL
-
批准号:2222604
-
项目类别:
-
资助金额:$22.3万
-
财政年份:1991
-
负责人:Charles J Gauntt
-
依托单位:
CHRONIC MYOCARDITIS IN A COXSACKIEVIRUS MURINE MODEL
-
批准号:3365094
-
项目类别:
-
资助金额:$20.33万
-
财政年份:1991
-
负责人:Charles J Gauntt
-
依托单位:
CHRONIC MYOCARDITIS IN A COXSACKIEVIRUS MURINE MODEL
-
批准号:3365093
-
项目类别:
-
资助金额:$20.46万
-
财政年份:1991
-
负责人:Charles J Gauntt
-
依托单位:
CHRONIC MYOCARDITIS IN A COXSACKIEVIRUS MURINE MODEL
-
批准号:3365095
-
项目类别:
-
资助金额:$20.81万
-
财政年份:1991
-
负责人:Charles J Gauntt
-
依托单位:
CHRONIC MYOCARDITIS IN A COXSACKIE VIRUS MURINE MODEL
-
批准号:2222603
-
项目类别:
-
资助金额:$21.55万
-
财政年份:1991
-
负责人:Charles J Gauntt
-
依托单位:
STUDIES OF COXSACKIEVIRUS-INDUCED MYOCARDITIS
-
批准号:3336345
-
项目类别:
-
资助金额:$10.96万
-
财政年份:1978
-
负责人:Charles J Gauntt
-
依托单位:
STUDIES OF COXSACKIEVIRUS-INDUCED MYOCARDITIS
-
批准号:3336344
-
项目类别:
-
资助金额:$10.82万
-
财政年份:1978
-
负责人:Charles J Gauntt
-
依托单位: